Quantcast

Latest Factor X Stories

2014-09-02 08:31:44

Results presented during ESC Congress 2014 Clinical Trial Update Hot Line session BARCELONA, Spain, Sept. 2, 2014 /PRNewswire/ -- Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) today announced data from a subgroup analysis of the phase 3 ENGAGE AF-TIMI 48 study, that explores the relationship between edoxaban dose, concentration and anti-factor Xa activity in patients with non-valvular atrial fibrillation (NVAF). The analysis also compared rates of major bleeding and...

2014-08-26 23:05:43

Kristine Kraft, partner at Schlichter, Bogard & Denton, LLP, reports on the findings of a new study published in the Journal of Neurosurgery regarding the increased difficulties of stopping bleeding events for patients using certain direct Factor Xa inhibitor medications, including Xarelto®. The attorneys at Schlichter, Bogard & Denton, LLP are offering free and confidential case reviews to those who allege to have suffered serious bleeding events after using Xarelto®....

2014-06-11 08:32:01

LONDON, June 11, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report: Coagulation Diagnostic Testing Marketshttp://www.reportbuyer.com/pharma_healthcare/diagnostics/coagulation_diagnostic_testing_markets_1.html Coagulation testing, which encompasses both laboratory and point of care (POC) testing, will continue to be one of the most important segments of the in vitro diagnostics market for the foreseeable future. Many of the new models of laboratory...

2014-04-29 08:34:35

Recently Released ACC/AHA Practice Guidelines Reinforce Unmet Need MENLO PARK, Calif., April 29, 2014 /PRNewswire/ -- Armetheon, Inc., today announced that it has reached agreement with the U.S. Food and Drug Administration (FDA) on a Special Protocol Assessment (SPA) for the final pivotal trial of tecarfarin. Tecarfarin is positioned to be the only oral anticoagulant (OAC) therapy for patients with prosthetic heart valves (PHV) specifically identified in the label. In addition, the...

2014-04-28 16:29:07

LONDON, April 28, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report: Antithrombotic Drugs: World Market 2013-2023 http://www.reportbuyer.com/pharma_healthcare/therapeutic/antithrombotic_drugs_world_market.html Report DetailsAntithrombotic agents - discover technological and commercial prospectsWhat does the future hold for treating conditions associated with thrombosis? Visiongain's updated report gives you forecasted revenues to 2023, explaining R&D...

2013-09-30 23:28:04

Reportbuyer.com just published a new market research report: Point of Care Coagulation Testing: World Market 2013-2023 London (PRWEB) September 30, 2013 Report Details In 2011, the global point of care diagnostics market was worth $13.8bn, with high single-digit growth from the year before. Despite being a vast and mature market, there are number of sectors likely to experience fast growth during the next 10 years. Much of this growth is linked to the prevalence of a number of diseases...

2013-06-27 23:52:49

Rockville, MD | 6/26/2013 | PRWeb – MarketResearch.com announces the addition of a new market research report in Pharmaceuticals to their product offering: New Oral Anticoagulants Markets http://www.marketresearch.com/land/product.asp?productid=7458266&progid=85535 (PRWEB) June 26, 2013 New Oral Anticoagulants Markets TriMarkPublications.com cites in its newly published “New Oral Anticoagulants Markets” report that the global anticoagulants market will spike to over $24 billion...


Word of the Day
tessitura
  • The prevailing range of a vocal or instrumental part, within which most of the tones lie.
This word is Italian in origin and comes from the Latin 'textura,' web, structure.